Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

AAVXF — Abivax S.A. SEC Filings | FilingIndex

AAVXFNasdaq

Abivax S.A.

Pharmaceutical Preparations · I0 · CIK 1956827

Abivax develops and commercializes innovative antiviral and anti-inflammatory drugs

+ Watch View on EDGAR ↗

47

Total filings

Jun 30, 2026

Last filing

12/31

Fiscal year end

All 6-K · 34 424B5 · 3 20-F · 3 SC 13G · 3 SC 13D/A · 2 SC 13D · 1 424B4 · 1

20-F20-FMar 23, 2026 20-F20-FMar 24, 2025 20-F20-FApr 5, 2024

Similar companies

Comparable business profile · signals at a glance

ASMBASSEMBLY BIOSCIENCES, INC.$455.0M+1.9%VALNValneva SE$507.8M+1.2%PCVXVaxcyte, Inc.$6.9B+0.7%AVTXAvalo Therapeutics, Inc.$775.9M-4.2%ARCTArcturus Therapeutics Holdings Inc.

$198.1M

-1.5%

RGNXREGENXBIO Inc.$344.3M+1.3%